spacer
home > pmps > winter 2017 > compliance made easy
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Compliance Made Easy

We have come a long way from the days of the neighbourhood apothecary, grinding and mixing ingredients to treat things he himself might have diagnosed, and for which he would follow the healing process. The apothecary took a hands-on role in healthcare, because it has long been known that patients have poor adherence records with medication and that noncompliance is a huge source of error when determining a treatmentís effectiveness. This has, therefore, been the driver for packaging initiatives.

The idea of measuring medication compliance electronically was pioneered by Aardex with smart vial caps over 20 years ago. These record the opening and closing of the vial cap as a proxy for medication taking, but are subject to the limitation that the patient can take any number of tablets or capsules from the vial during a single opening.

Smart Blister Packages

The blister package was patented in 1947 as a means of facilitating medication compliance, but sat on the shelf for almost 50 years before making its appearance in the clinical marketplace. Despite this long wait, the claim that blister packaging would improve patient adherence has never been demonstrated due to the lack of a means of measuring this accurately. However, there have been extensive efforts to make the use of this format safer and more user-friendly, for which a number of Health and Care Professionals Council awards have been given.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Allan Wilson, MD, PhD, co-founded Information Mediary Corporation in 2002 and now devotes his time to the study of medication compliance. He has worked as a consultant in the healthcare field for both public and private sectors, and his research interests lie in clinical pharmacology, biotechnology and large data systems. Allan was Professor and Head of the Section of Addiction Psychiatry at the University of Ottawa, Canada, for more than 25 years.
spacer
Allan Wilson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Companyís novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies

PCI Pharma Services

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even more burdensome over the last several years as the industry pushes the boundaries of innovation. This is because newer, often more-complex therapies not only increase risk in drug development but also drive costs even higher. A recent analysis of the investment needed to develop a new prescription medicine shows the total cost can be as high as $2.6 billion (1). That number becomes even more staggering when you consider the fact that only about 12 percent of drug candidates that make it to Phase I testing are eventually approved by the FDA (2). The investment companies lose as a result may be too devastating to their bottom line to ever recover.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement